Jiangsu Kanion PharmaceuticalLtd Balance Sheet Health
Financial Health criteria checks 6/6
Jiangsu Kanion PharmaceuticalLtd has a total shareholder equity of CN¥5.3B and total debt of CN¥1.9M, which brings its debt-to-equity ratio to 0.04%. Its total assets and total liabilities are CN¥7.1B and CN¥1.7B respectively. Jiangsu Kanion PharmaceuticalLtd's EBIT is CN¥405.6M making its interest coverage ratio -7.5. It has cash and short-term investments of CN¥2.3B.
Key information
0.04%
Debt to equity ratio
CN¥1.93m
Debt
| Interest coverage ratio | -7.5x |
| Cash | CN¥2.28b |
| Equity | CN¥5.34b |
| Total liabilities | CN¥1.72b |
| Total assets | CN¥7.05b |
Recent financial health updates
No updates
Recent updates
With EPS Growth And More, Jiangsu Kanion PharmaceuticalLtd (SHSE:600557) Makes An Interesting Case
Aug 19
Here's Why Jiangsu Kanion PharmaceuticalLtd (SHSE:600557) Has Caught The Eye Of Investors
May 21Shareholders Can Be Confident That Jiangsu Kanion PharmaceuticalLtd's (SHSE:600557) Earnings Are High Quality
Apr 25Jiangsu Kanion Pharmaceutical Co.,Ltd.'s (SHSE:600557) Share Price Boosted 34% But Its Business Prospects Need A Lift Too
Mar 04Jiangsu Kanion Pharmaceutical Co.,Ltd. (SHSE:600557) Shares Fly 34% But Investors Aren't Buying For Growth
Mar 04Financial Position Analysis
Short Term Liabilities: 600557's short term assets (CN¥3.9B) exceed its short term liabilities (CN¥1.6B).
Long Term Liabilities: 600557's short term assets (CN¥3.9B) exceed its long term liabilities (CN¥158.4M).
Debt to Equity History and Analysis
Debt Level: 600557 has more cash than its total debt.
Reducing Debt: 600557's debt to equity ratio has reduced from 18.7% to 0.04% over the past 5 years.
Debt Coverage: 600557's debt is well covered by operating cash flow (50656.3%).
Interest Coverage: 600557 earns more interest than it pays, so coverage of interest payments is not a concern.